Nissen, Alexander
Hynek, Kamila Angelika
Scales, David
Hilden, Per Kristian
Straiton, Melanie
Article History
Received: 11 May 2022
Accepted: 5 August 2022
First Online: 24 August 2022
Declarations
:
: All potential participants were given a detailed information letter and consent form, detailing the study and what participation entailed. The voluntary nature of the study was stressed and procedures for how participants could withdraw were described. All information was given in Arabic. The informed consent form had to be signed and returned together with the questionnaire. The Regional Committees for Medical and Health Research Ethics (REK) – Region Southeast (A) in Norway granted ethical approval for the study (reference number 2017/1252). All parts of the study were conducted in accordance with the protocol approved by REK and in line with relevant regulations.
: NA
: None.